Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo

被引:21
作者
Hornbuckle, LA [1 ]
Edgerton, DS [1 ]
Ayala, JE [1 ]
Svitek, CA [1 ]
Oeser, JX [1 ]
Neal, DW [1 ]
Cardin, S [1 ]
Cherrington, AD [1 ]
O'Brien, RM [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2001年 / 281卷 / 04期
关键词
glucose; 6-phosphate; glucose-6-phosphatase; insulin; cyclic adenosine monophosphate; glucocorticoids; gene transcription;
D O I
10.1152/ajpendo.2001.281.4.E713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The regulation of glucose-6-phosphatase (G-6-Pase) catalytic subunit and glucose 6-phosphate (G-6-P) transporter gene expression by insulin in conscious dogs in vivo and in tissue culture cells in situ were compared. In pancreatic-clamped, euglycemic conscious dogs, a 5-h period of hypoinsulinemia led to a marked increase in hepatic G-6-Pase catalytic subunit mRNA; however, G-6-P transporter mRNA was unchanged. In contrast, a 5-h period of hyperinsulinemia resulted in a suppression of both G-6-Pase catalytic subunit and G-6-P transporter gene expression. Similarly, insulin suppressed G-6-Pase catalytic subunit and G-6-P transporter gene expression in H4IIE hepatoma cells. However, the magnitude of the insulin effect was much greater on G-6-Pase catalytic subunit gene expression and was manifested more rapidly. Furthermore, cAMP stimulated G-6-Pase catalytic subunit expression in H4IIE cells and in primary hepatocytes but had no effect on G-6-P transporter expression. These results suggest that the relative control strengths of the G-6-Pase catalytic subunit and G-6-P transporter in the G-6-Pase reaction are likely to vary depending on the in vivo environment.
引用
收藏
页码:E713 / E725
页数:13
相关论文
共 70 条
[21]   Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene [J].
Ebert, DH ;
Bischof, LJ ;
Streeper, RS ;
Chapman, SC ;
Svitek, CA ;
Goldman, JK ;
Mathews, CE ;
Leiter, EH ;
Hutton, JC ;
O'Brien, RM .
DIABETES, 1999, 48 (03) :543-551
[22]   α- and β-cell responses to small changes in plasma glucose in the conscious dog [J].
Flattem, N ;
Igawa, K ;
Shiota, M ;
Emshwiller, MG ;
Neal, DW ;
Cherrington, AD .
DIABETES, 2001, 50 (02) :367-375
[23]   REGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE-EXPRESSION BY INSULIN - USE OF THE STABLE TRANSFECTION APPROACH TO LOCATE AN INSULIN RESPONSIVE SEQUENCE [J].
FOREST, CD ;
OBRIEN, RM ;
LUCAS, PC ;
MAGNUSON, MA ;
GRANNER, DK .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (09) :1302-1310
[24]  
Foster JD, 1997, P SOC EXP BIOL MED, V215, P314
[25]  
Foufelle F, 1998, Curr Opin Clin Nutr Metab Care, V1, P323, DOI 10.1097/00075197-199807000-00002
[26]  
FRIEDMAN JE, 1993, J BIOL CHEM, V268, P12952
[27]   Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib [J].
Gerin, I ;
Veiga-da-Cunha, M ;
Achouri, Y ;
Collet, JF ;
Van Schaftingen, E .
FEBS LETTERS, 1997, 419 (2-3) :235-238
[28]   A nucleoprotein complex containing CCAAT/enhancer-binding protein β interacts with an insulin response sequence in the insulin-like growth factor-binding protein-1 gene and contributes to insulin-regulated gene expression [J].
Ghosh, AK ;
Lacson, R ;
Liu, PX ;
Cichy, SB ;
Danilkovich, A ;
Guo, SD ;
Unterman, TG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) :8507-8515
[29]   MOLECULAR PHYSIOLOGY AND GENETICS OF NIDDM - IMPORTANCE OF METABOLIC STAGING [J].
GRANNER, DK ;
OBRIEN, RM .
DIABETES CARE, 1992, 15 (03) :369-395
[30]   Insulin suppresses transactivation by CAAT/enhancer-binding proteins β (C/EBPβ) -: Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPβ [J].
Guo, SD ;
Cichy, SB ;
He, XW ;
Yang, QY ;
Ragland, M ;
Ghosh, AK ;
Johnson, PF ;
Unterman, TG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) :8516-8523